Human trial begins of Imperial College London's candidate Covid-19 vaccine

Imperial College London's vaccine candidate is being developed and trialled with the help of more than £41 million in funding from the UK government and a further £5 million in philanthropic donations

The human trial of Imperial College London's candidate coronavirus vaccine began on Tuesday with the first healthy volunteer receiving a small dose of it.

It is a second such trial in the UK. The first candidate vaccine that went for the human trial was from Oxford University.

The clinical team, which delivered a small dose of the vaccine to the participant at a West London facility, is closely monitoring the participant and report that they are in good health with no safety concerns, said the college in a press release.

The trials are the first test of a new self-amplifying RNA (saRNA) technology,